Tata Chemicals Q2 FY27 consolidated revenue Rs 4,177 cr; PAT Rs (50) cr

What the numbers show

• Net margin was -1.20% of revenue, down 516 bps from 3.97%.
• Total expenses rose 14.0% while revenue rose 7.7%.

• Basis & period: Consolidated statement of financial results for the quarter ended 30 September, 2026 (Q2 FY27), compared with the quarter ended 30 September, 2025 as per the statement of consolidated financial results.

• Revenue from operations: Rs 4,177.00 cr (Q2 FY27) vs Rs 3,877.00 cr (Q2 FY26), from line "Revenue from operations" in the statement of consolidated financial results.

• Other income: Rs 95.00 cr vs Rs 138.00 cr, from line "Other income".

• Total income (1a + 1b): Rs 4,272.00 cr vs Rs 4,015.00 cr, from line "Total income (1a + 1b)".

• Total expenses (2a to 2i): Rs 4,298.00 cr vs Rs 3,769.00 cr, from line "Total expenses (2a to 2i)".

• Cost of materials consumed: Rs 653.00 cr vs Rs 733.00 cr, from line "Cost of materials consumed".

• Purchases of stock-in-trade: Rs 154.00 cr vs Rs 68.00 cr, from line "Purchases of stock-in-trade".

• Changes in inventories of finished goods, work-in-progress and stock-in-trade: Rs 177.00 cr vs Rs 167.00 cr, from line "Changes in inventories of finished goods, work-in-progress and stock-in-trade".

• Employee benefits expense: Rs 567.00 cr vs Rs 514.00 cr, from line "Employee benefits expense (note 3)".

• Finance costs: Rs 151.00 cr vs Rs 144.00 cr, from line "Finance costs".

• Depreciation and amortisation expense: Rs 351.00 cr vs Rs 285.00 cr, from line "Depreciation and amortisation expense".

• Other expenses: Rs 761.00 cr vs Rs 700.00 cr, from line "Other expenses".

• (Loss) / profit before exceptional items, share of profit of joint ventures and associate and tax (1-2): Rs (26.00) cr vs Rs 246.00 cr, from line "(Loss) / profit before exceptional items, share of profit of joint ventures and associate and tax (1-2)".

• Exceptional items (net): Rs - vs Rs (65.00) cr, from line "Exceptional items (net) (note 2)".

• (Loss) / profit before share of profit of joint ventures and associate and tax (3+4): Rs (26.00) cr vs Rs 181.00 cr, from line "(Loss) / profit before share of profit of joint ventures and associate and tax (3+4)".

• Share of (loss) / profit of joint ventures and associate (net of tax): Rs 20.00 cr vs Rs 55.00 cr, from line "Share of (loss) /profit of joint ventures and associate (net of tax)".

• (Loss) / profit before tax (5+6): Rs (6.00) cr vs Rs 236.00 cr, from line "(Loss) / profit before tax (5+6)".

• Current tax: Rs 57.00 cr vs Rs 55.00 cr, from line "Current tax (note 4)".

• Deferred tax: Rs (13.00) cr vs Rs 27.00 cr, from line "Deferred tax".

• Total tax expenses (8a + 8b): Rs 44.00 cr vs Rs 82.00 cr, from line "Total tax expenses (8a + 8b)".

• (Loss) / profit for the period (7-8): Rs (50.00) cr vs Rs 154.00 cr, from line "(Loss) / profit for the period (7-8)".

• Earnings per share - Basic and Diluted: Rs (4.79)* vs Rs 3.02*, from line "Earnings per share (in ) - Basic and Diluted" (*Not annualised).

In Q2 FY27, consolidated revenue from operations as per the statement of consolidated financial results rose to Rs 4,177.00 cr from Rs 3,877.00 cr in the corresponding quarter of the previous year. Total income (1a + 1b) increased to Rs 4,272.00 cr from Rs 4,015.00 cr. Total expenses (2a to 2i) moved up to Rs 4,298.00 cr from Rs 3,769.00 cr, with employee benefits expense at Rs 567.00 cr versus Rs 514.00 cr, power and fuel (within expenses but not separately required in this recap) included in total expenses, and other expenses at Rs 761.00 cr versus Rs 700.00 cr.

The company reported a loss before tax (5+6) of Rs (6.00) cr for the quarter, compared with a profit before tax of Rs 236.00 cr a year earlier, as per the statement of consolidated financial results. After total tax expenses of Rs 44.00 cr versus Rs 82.00 cr, the loss for the period (7-8) stood at Rs (50.00) cr against a profit of Rs 154.00 cr in the corresponding prior quarter. Basic and diluted earnings per share were Rs (4.79)* compared with Rs 3.02* a year ago, as disclosed in the earnings per share line of the statement of consolidated financial results (*Not annualised).